{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "2021", "item": "https://www.patentleaderboard.com/2021/"}, {"@type": "ListItem", "position": 3, "name": "Achaogen", "item": "https://www.patentleaderboard.com/2021/company/achaogen"}, {"@type": "ListItem", "position": 4, "name": "James Aggen", "item": "https://www.patentleaderboard.com/2021/inventor/fl:ja_ln:aggen-1"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
JA

James Aggen — 3 Patents in 2021

KSKodiak Sciences: 1 patents #5 of 14Top 40%
RMRevolution Medicines: 1 patents #9 of 38Top 25%
Westwood, MA: #4 of 44 inventorsTop 10%
Massachusetts: #1,400 of 14,123 inventorsTop 10%
Overall (2021): #79,871 of 548,734Top 15%
3 Patents 2021

Issued Patents 2021

Showing 1–3 of 3 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
11155610 Dual PDGF/VEGF antagonists Daniel Victor Perlroth, Stephen A. Charles, Didier Benoit, Wayne To, Lidia Mosyak +4 more 2021-10-26 $80,815,000
11117915 Antibacterial aminoglycoside analogs Adam A. Goldblum, Martin S. Linsell, Paola Dozzo, Heinz Ernst Moser, Darin James Hildebrandt +1 more 2021-09-14
10980889 C40-, C28-, and C-32-linked rapamycin analogs as mTOR inhibitors Jennifer Pitzen, Micah James Gliedt, G. Leslie Burnett, Gert Kiss, Christopher Semko +6 more 2021-04-20 $48,193,000